Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Research Abstract |
We have tried to set up the treatment of Duchenne Muscular Dystrophy by promoting mutated exon skipping by using a chemical compound. We found that TG003, a specific inhibitor for Clk kinases, promotes exon skipping in the patient cells. We also comprehensively analyzed the effect of TG003 in pre-mRNA splicing and detected the introns whose excision is affected.
|